CUSIP No. 76029N106 | 13G | Exhibit 99.1 |
AGREEMENT
Pursuant to Rule13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of Common Stock of Replimune Group, Inc.
Dated: February 13, 2019 | ||
OMEGA FUND IV, L.P. | ||
BY: | Omega Fund IV GP, L.P. | |
ITS: | GENERAL PARTNER | |
BY: | Omega Fund IV GP Manager, Ltd. | |
ITS: | GENERAL PARTNER | |
By: | /s/ Anne-Mari Paster | |
Director | ||
OMEGA FUND IV GP, L.P | ||
BY: | Omega Fund IV GP Manager, Ltd. | |
ITS: | GENERAL PARTNER | |
By: | /s/ Anne-Mari Paster | |
Director | ||
OMEGA FUND IV GP MANAGER, LTD. | ||
By: | /s/ Anne-Mari Paster | |
Director | ||
* | ||
Richard Lim | ||
* | ||
Otello Stampacchia | ||
/s/ Anne-Mari Paster |
Anne-Mari Paster, asAttorney-in-Fact, pursuant to that Power of Attorney filed with the Securities and Exchange Commission on July 19, 2018 in connection with a Form 3 filing for Replimune Group, Inc., which power of attorney is incorporated herein by reference.*